Cosentyx 150 mg

Cosentyx contains the active ingredient Secukinumab, a biologic medication used to treat chronic inflammatory conditions such as moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It works by inhibiting interleukin-17A (IL-17A), a protein that plays a key role in causing inflammation in autoimmune diseases.

Indications:

• Moderate to severe plaque psoriasis

• Psoriatic arthritis

• Ankylosing spondylitis

• Non-radiographic axial spondyloarthritis

Usage:

• Administered as a subcutaneous injection as prescribed by a physician

• Dosage depends on the specific condition and patient response

• Initial doses are often given under medical supervision

Warnings and Precautions:

• Not to be used during active infections

• TB screening is recommended before starting treatment

• Use with caution in patients with immune system disorders

• Store refrigerated at 2–8°C (36–46°F)